Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/14728222.2021.1953475 http://scihub22266oqcxt.onion/10.1080/14728222.2021.1953475 34232801!8330012!34232801     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Opin+Ther+Targets 2021 ; 25 (6): 509-519 Nephropedia Template TP {{tp|p=34232801|t=2021. Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets |pdf=|usr=}}{{34232801}} gab.com Text Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets JO: Expert Opin Ther Targets http://www.kidney.de/pget.php?&tw=1&pmid=34232801 #FOAvip INTRODUCTION: Although SARS-CoV-2 primarily manifests in the form of respiratory symptoms, emerging evidence suggests that the disease is associated with numerous neurological complications, such as stroke and Guillain-Barre syndrome. Hence, further research is necessary to seek possible therapeutic targets in the CNS for effective management of these complications. AREAS COVERED: This review examines the neurological complications associated with SARS-CoV-2 infections and the possible routes of infection. It progresses to illuminate the possible therapeutic targets for effective management of these neuromodulatory effects and the repurposing of drugs that could serve this purpose. To this end, literature from the year 1998-2021 was derived from PubMed. EXPERT OPINION: The neurological manifestations associated with COVID-19 may be related to poor prognosis and higher comorbidity. Identification of the key molecular targets in the brain that are potential indicators of the observed neuropathology, such as inflammatory mediators and chromatin modifiers, is key. The repurposing of existing drugs to target potential candidates could reduce the mortality attributed to these associated neurological complications. Twit Text FOAVip Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets ????Expert Opin Ther Targets http://www.kidney.de/pget.php?&tw=1&pmid=34232801 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34232801 #FOAvip English Wikipedia <ref>{{Cite pmid|34232801}}</ref> Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets #MMPMID34232801 Kumar S; Shanker OR; Kumari N; Tripathi M; Chandra PS; Dixit AB; Banerjee J Expert Opin Ther Targets 2021[Jun]; 25 (6): 509-519 PMID34232801show ga INTRODUCTION: Although SARS-CoV-2 primarily manifests in the form of respiratory symptoms, emerging evidence suggests that the disease is associated with numerous neurological complications, such as stroke and Guillain-Barre syndrome. Hence, further research is necessary to seek possible therapeutic targets in the CNS for effective management of these complications. AREAS COVERED: This review examines the neurological complications associated with SARS-CoV-2 infections and the possible routes of infection. It progresses to illuminate the possible therapeutic targets for effective management of these neuromodulatory effects and the repurposing of drugs that could serve this purpose. To this end, literature from the year 1998-2021 was derived from PubMed. EXPERT OPINION: The neurological manifestations associated with COVID-19 may be related to poor prognosis and higher comorbidity. Identification of the key molecular targets in the brain that are potential indicators of the observed neuropathology, such as inflammatory mediators and chromatin modifiers, is key. The repurposing of existing drugs to target potential candidates could reduce the mortality attributed to these associated neurological complications. |COVID-19/*complications/*physiopathology/virology[MESH] |Humans[MESH] |Nervous System Diseases/*etiology[MESH]Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic t(epmc).pdf DeepDyve Pubget Overpricing